SHARDACROPNSE25 July 2025

Sharda Cropchem Limited has informed the Exchange about Investor Presentation

Sharda Cropchem Limited

25th July, 2025

To,

National Stock Exchange of India Limited Exchange Plaza, 5th Floor, Plot No. C/1, G-Block, Bandra Kurla Complex, Bandra (E), Mumbai – 400 051

BSE Limited Phiroze Jeejeebhoi Tower, Dalal Street, Mumbai – 400 001

Trading Symbol: SHARDACROP

Scrip Code: 538666

Subject: Investors / Analyst’s Presentation for the Quarter ended 30th June, 2025

Dear Sir/Madam,

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), we are enclosing herewith the presentation to be made to the Investors/Analysts on the Unaudited Financial Results of the Company for the quarter ended 30th June, 2025.

The presentation is also being uploaded on the website of the Company www.shardacropchem.com the Listing Regulations.

in accordance with Regulation 46 of

We request you to take the same on record.

Yours Sincerely,

__________________ Jetkin Gudhka Company Secretary & Compliance Officer

Encl.: As above

GROWING STRONGER, GOING FURTHER.

Investor Presentation July 2025

SAFE HARBOR

This presentation has been prepared by and is the sole responsibility of Sharda Cropchem Limited (the “Company”). By accessing this presentation, you are agreeing to be bound by the trailing restrictions.

This presentation does not constitute or form part of any offer or invitation or inducement to sell or issue, or any solicitation of any offer or recommendation to purchase or subscribe for, any securities of the Company, nor shall it or any part of it or the fact of its distribution form the basis of, or be relied on in connection with, any contract or commitment thereof. In particular, this presentation is not intended to be a prospectus or offer document under the applicable laws of any jurisdiction, including India. No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained in this presentation. Such information and opinions are in all events not current after the date of this presentation. There is no obligation to update, modify or amend this communication or to otherwise notify the recipient if the information, opinion, projection, forecast or estimate set forth herein, changes or subsequently becomes inaccurate.

Certain statements contained in this presentation that are not statements of historical fact constitute “forward-looking statements.” You can generally identify forward looking statements by terminology such as “aim”, “anticipate”, “believe”, “continue”, “could”, “estimate”, “expect”, “intend”, “may”, “objective”, “goal”, “plan”, “potential”, “project”, “pursue”, “shall”, “should”, “will”, “would”, or other words or phrases of similar import. These forward-looking statements involve known and unknown risks, uncertainties, assumptions and other factors that may cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements or other projections. Important factors that could cause actual results, performance or achievements to differ materially include, among others: (a) our ability to successfully implement our strategy, (b) our growth and expansion plans, (c) changes in regulatory norms applicable to the Company, (d) technological changes, (e) investment income, (f) cash flow projections, and (g) other risks.

This presentation is for general information purposes only, without regard to any specific objectives, financial situations or informational needs of any particular person. The Company may alter, modify or otherwise change in any manner the content of this presentation, without obligation to notify any person of such change or changes.

GROWING STRONGER, GOING FURTHER.

About Sharda Cropchem Limited

“We are a fast-growing global agrochemicals company with a peer position in the generic crop protection chemicals industry. Our vast and growing library of dossiers and IPRs provide us solid foundations for growth in the global marketplace, especially in Advanced Markets such as Europe, North America and Latin America. It equips us with the ability to operate in a diversified range of formulations and generic active ingredients space globally”

AGROCHEMICAL FOCUSED COMPANY

Sharda Cropchem is an Intellectual Property (IP) driven company engaged in marketing and distribution of wide range of formulations and generic active ingredients

Asset Light Business Model : Efficiently channelizing time and resources for strengthening core competency of identifying generic molecules and registration opportunities which offer scalable growth with limited capital requirements

Large Pipeline of Registrations* : Procured 2,981 registrations. Additionally, it has filed 1,021 applications for registrations globally pending at different stages

Diversified Sourcing Arrangements : Enduring relationship with multiple manufacturers and formulators enables to source and supply formulations or generic active ingredients at competitive prices

Consistently Increasing Global Presence : With diversified range of product portfolio, Company has grown by expanding business operations in 80+ countries, across Europe, NAFTA, Latin America and ROW

Widespread Distribution Network : Presence in the entire agrochemical value chain with 525 third party distributors and 500+ sales force serving the Company’s esteemed clientele in 80+ countries

*As on 30th June 2025

Company’s apt domain knowledge and experience gives substantial competitive advantage for expanding business in existing markets and new geographies

ASSET LIGHT BUSINESS MODEL

Overall Agrochemical Value Chain

Sharda’s Operating Area

√

Basic & Applied Research

Identification

Registration

Active Ingredient Manufacturing

Formulation & Packaging

Marketing & Distribution

Focus on identification of generic molecules, preparing dossiers, seeking registrations, marketing & distributing formulations through third-party distributors and/or own sales force

Manufacturing of AIs and formulations is outsourced

Acts as a key differentiator from an innovator company, allowing the Company to save its capital, time and resources on R&D

Highly flexible operating model resulting in :

• Overall cost competitiveness • Efficient management of fluctuating market demand across various geographies

• Offering wide range of formulations and AIs

GROWING STRONGER, GOING FURTHER.

INCREASING GLOBAL PRESENCE WITH WIDESPREAD DISTRIBUTION

Presence

80+ countries

across Europe, NAFTA, LATAM & RoW

Global Resource Deployment

500+

Distributors

525+

CAPEX incurred in Q1 FY26 Rs. 114 Cr.

Over the years, the Company has built a strong brand franchise within our global markets; we are benefiting through the economies of scale in our portfolio and leveraging value of our supply chain to deliver value to our customers across geographies

In addition to newer markets, the wide global presence has allowed us to find new, specialised sales and local marketing talent.

Successfully adopted a factory-to- farmer approach to become a one- stop solution provider to our global customers

Strengthening and widening the sales force in Europe, USA, Canada, Mexico, Colombia, South Africa, India, and rest of the world, in addition to third party distributors with a goal to enhance its presence in the agrochemical value chain

It enables the Company to penetrate its formulations and generic active ingredients in various countries backed by the third-party distributors and presence of its own sales force

Company has gained a great deal from globalization, including new customers and diverse geocentric revenue streams. Over the years, we have mastered flexibility and adopted innovative ways to grow our business overseas

GROWING STRONGER, GOING FURTHER.

The Sharda Advantage

Global Reach

Wide Product Range

Healthy Relationships with Suppliers

Quality with Affordability

Faster Sales Service

One Stop Solution Provider for Crop Care Products

WAY FORWARD

Forward Integration - Build Sales Force

✓ Leverage market presence and execution capabilities

✓ Adopt the factory to farmer approach and be a one stop

solution provider

✓ Strategy on ground in different regions of NAFTA, Europe,

LATAM and other key markets in ROW

Expand & Strengthen Distribution Presence

✓ Expand geographical reach using existing library of dossiers

✓ Two-fold strategy of further penetrating existing markets and

entering new markets

Continual Investment in Product Registrations

✓ Continue to identify generic molecules going off patent

✓ Investing in preparing dossiers and seeking registrations in

own name

Focus on Operational Efficiencies

✓ Accelerated focus on revenue generating investments

✓ Margin improvements

✓ Better cost management and eliminate NVAs

GROWING STRONGER, GOING FURTHER.

INDUSTRY OUTLOOK & GROWTH DRIVERS

Global crop protection (In Billion USD) – CAGR of 3.96%

INDUSTRY DRIVERS

+3.96%

141.7

96.1

FY24

FY33e

Source : Annual Report (FY25)

A Growing Population: Global population is projected to rise from 7.6 Bn in 2025 to 8.6 Bn by 2030 and 9.8 Bn by 2050 placing unprecedented pressure on global food and protein systems

A growing middle class fuels demand for increased food and protein production, which in turn drives demand for grain to support growth

Fewer arable acres per capita means that products need to continue to maximise farmer yields; arable land is expected to decrease from half an acre per person today to less than one-third of an acre per person by 2050

GROWING STRONGER, GOING FURTHER.

Experienced Management

Mr. Ramprakash V. Bubna Chairman & Managing Director

Mr. Ashish Bubna Whole Time Director

Mr. Manish Bubna Whole Time Director

✓ Holds a Bachelor’s Degree of Technology in Chemical

✓ Holds a Bachelor’s Degree in Commerce from the

Engineering from IIT, Bombay

University of Mumbai

✓ Holds a Bachelor’s Degree in Chemical Engineering from the Department of Chemical Technology, Bombay University.

✓ He has over 57 years of experience in chemicals,

✓ Over 34 years of experience in marketing of chemicals,

✓ Over 32 years of experience in chemicals, agrochemicals and

agrochemicals and related businesses

agrochemicals and related businesses.

related businesses

✓ He is responsible for the Company’s overall business

✓ Instrumental in strategizing early investment in product

✓ Spearheaded the Company’s foray into the conveyor belt and

operations and strategy

registrations and building the library of product dossiers.

✓ Responsible for marketing, procurement, registrations and logistics functions of the agrochemical business.

general chemicals business

✓ Also oversees the information technology, logistics and

documentation functions of the Company

Q1 FY26 Financial Highlights

Q1 FY26: SEGMENT WISE HIGHLIGHTS

Agrochemical Segment

Non-Agrochemical Segment

TOTAL REVENUES

Cr.

87%

86%

13%

14%

% of Revenue

100%

+25%

846

+31%

139

679

106

+25%

985

785

Q1 FY25

Q1 FY26

Q1 FY25

Q1 FY26

Q1 FY25

Q1 FY26

GROWING STRONGER, GOING FURTHER.

On Consolidated Basis

Q1 FY26: PRODUCT WISE HIGHLIGHTS (Agrochemical Segment)

Herbicides

Insecticides

Fungicides

Cr.

TOTAL REVENUES (Agrochemical Segment)

47%

50%

23%

24%

31%

26%

% of Revenue

100%

+32%

420

319

+34%

205

153

+7%

222

207

+25%

846

679

Q1 FY25

Q1 FY26

Q1 FY25

Q1 FY26

Q1 FY25

Q1 FY26

Q1 FY25

Q1 FY26

GROWING STRONGER, GOING FURTHER.

On Consolidated Basis

Q1 FY26: REGION WISE BREAKUP (Agrochemical Segment)

Europe

+43%

62%

523

54%

364

NAFTA Region

36%

249

+3%

30%

256

Q1 FY25

Q1 FY26

Q1 FY25

Q1 FY26

LATAM Region

+18%

RoW

-20%

Cr.

TOTAL REVENUES (Agrochemical Segment)

+25%

846

679

Q1 FY25

Q1 FY26

Q1 FY25

Q1 FY26

GROWING STRONGER, GOING FURTHER.

Q1 FY25

Q1 FY26

% of Revenue

On Consolidated Basis

Q1 FY26: REGION WISE BREAKUP (Non - Agrochemical Segment)

Europe

+33%

16%

15%

NAFTA Region

65%

+36%

66%

Q1 FY25

Q1 FY26

Q1 FY25

Q1 FY26

LATAM Region

11%

RoW

+29%

Cr.

TOTAL REVENUES (Non - Agrochemical Segment)

+31%

139

106

Q1 FY25

Q1 FY26

Q1 FY25

Q1 FY26

GROWING STRONGER, GOING FURTHER.

Q1 FY25

Q1 FY26

% of Revenue

On Consolidated Basis

Q1 FY26 : FINANCIAL HIGHLIGHTS

Revenues & GP Margin

29.2%

35.5%

+25%

985

785

EBITDA

+67%

142

Cr.

Profit After Tax

+424%

143

Q1 FY25

Q1 FY26

Q1 FY25

Q1 FY26

Q1 FY25

Q1 FY26

✓ Revenue in Q1 FY26 increased by 25% primarily driven by high volume growth of ~13%. We saw volume growth across Europe

✓ Agrochemical volumes grew by 11.4% in Q1 FY26

✓ Non-Agrochemical volumes grew by 58.5% in Q1 FY26

✓ Gross Margins have improved 630 basis points to 35.5%. These margins are expected to remain at these levels in FY26

✓ EBITDA for the quarter grew by 67% to Rs. 142 crores as compared to Rs. 85 crores in Q1 FY25 with EBITDA Margins at 14.4%

✓ PAT for the quarter grew more than 4x to Rs. 143 crores as compared to Rs. 27 crores in Q1 FY25

GROWING STRONGER, GOING FURTHER.

On Consolidated Basis

STRONG BALANCE SHEET

Working Capital (in Days)

Total Equity

118 days

146

111

100 days

Reduced Working Capital by 18 days

107

Mar-25

Jun-25

Inventory Days

Recievable Days

Creditor Days

RoCE*

16.0%

RoE*

12.8%

Rs. 2,649 crores (as on 30th June, 2025)

Rs. 2,501 crores as on Mar’25

Cash, Bank & Liquid Investments

Rs. 791 crores (as on 30th June, 2025)

Rs. 558 crores as on Mar’25

* ROCE = EBIT / Average Capital Employed ; RoE = PAT / Average Equity * As on 31st March 2025

GROWING STRONGER, GOING FURTHER.

On Consolidated Basis

Annexure

Q1 FY26 FINANCIAL HIGHLIGHTS

Particulars

Revenue from Operations

COGS

Gross Profit

Gross Margin %

Employee Expenses

Other Expenses

EBITDA

EBITDA Margin %

Forex (Gain)/Loss

Depreciation

Other Income

EBIT

EBIT Margin %

Finance Cost

PBT

Tax Expense

PAT

PAT Margin %

Earnings Per Share (EPS) In Rs.

Q1 FY26

Q1 FY25

984.8

635.6

349.2

35.5%

14.9

192.1

142.2

14.4%

-73.1

78.1

32.5

169.7

17.2%

0.6

169.1

26.3

142.8

14.5%

15.83

785.1

556.2

228.9

29.2%

11.2

132.4

85.4

10.9%

8.3

64.8

19.3

31.5

4.0%

0.8

30.8

3.5

27.3

3.5%

3.02

Cr.

Y-o-Y

25%

53%

67%

438%

449%

424%

GROWING STRONGER, GOING FURTHER.

On Consolidated Basis

KEY FINANCIAL PERFORMANCE INDICES

Revenue

EBITDA & EBITDA Margin*

Profit After Tax & PAT Margin

Cr.

19.0%

20.4%

17.6%

10.1%

15.8%

9.6%

9.8%

8.5%

1.0%

7.0%

3,580

4,045

3,163

4,320

2,396

729

713

682

349

342

455

318

229

FY21

FY22

FY23

FY24

FY25

FY21

FY22

FY23

FY24

FY25

FY21

FY22

FY23

304

FY25

FY24

RoCE

RoE

Cash, Bank & Liquid Investments^

25.7%

20.2%

20.8%

19.8%

16.5%

15.2%

16.0%

3.4%

FY21

FY22

FY23

FY24

FY25

FY21

FY22

FY23

* EBITDA is excluding IA & IAUD write-off

^ Total Cash & Cash Equivalents (Includes FDs of Rs. 128 crores clubbed in Non Current Other Financial Assets)

GROWING STRONGER, GOING FURTHER.

12.8%

276

262

325

375

558

1.4%

FY24

FY25

FY21

FY22

FY23

FY24

FY25

On Consolidated Basis

HISTORICAL PROFIT & LOSS

Particulars

Revenue from Operations

COGS

Gross Profit

Gross Margin %

Employee Expenses

Other Expenses

EBITDA*

EBITDA Margin %

Forex (Gain)/Loss

Depreciation

Other Income

EBIT

EBIT Margin %

Finance Cost

PBT

Tax Expense

PAT

PAT Margin %

Earnings Per Share (EPS) In Rs.

* EBITDA is excluding IA & IAUD write-off

FY25

4,319.9

3,028.1

1,291.8

29.9%

52.0

626.3

681.6

15.8%

17.9

274.7

59.5

380.4

8.8%

2.1

378.3

73.9

304.4

7.0%

33.74

FY24

3,163.0

2,342.4

820.6

25.9%

42.4

494.9

318.1

10.1%

0.4

267.1

59.8

75.5

2.4%

3.6

71.9

40.0

31.9

1.0%

3.53

FY23

4,045.2

2,860.8

1,184.4

29.3%

44.8

438.9

712.6

17.6%

57.6

248.1

40.3

435.3

10.8%

4.5

430.7

88.8

342.0

8.5%

37.90

FY22

3,579.8

2,499.8

1,080.0

30.2%

44.2

336.4

728.6

20.4%

16.5

245.3

28.9

466.5

13.0%

2.2

464.2

115.0

349.3

9.8%

38.71

Cr.

FY21

2,395.6

1,636.0

759.7

31.7%

37.3

305.5

455.2

19.0%

-19.9

170.4

45.9

312.2

13.0%

2.8

309.5

80.2

229.2

9.6%

25.40

GROWING STRONGER, GOING FURTHER.

On Consolidated Basis

BALANCE SHEET – EQUITY & LIABILITIES

Equities & Liabilities Shareholder's Funds Equity and Share Capital Other Equity Non-controlling Interest Total Equity

Non-Current Liabilities Borrowings Trade Payables Lease Liabilities Other Financial Liabilities Provisions Deferred Tax Liabilities (net) Total Non-Current Liabilities

Current Liabilities Borrowings Lease Liabilities Trade Payables Other Financial Liabilities Other Current Liabilities Current Tax Liabilities Provisions Total Current Liabilities Total Equity & Liabilities

FY25

90.2 2,410.4 0.4 2,501.0

- - - 63.0 1.3 173.8 238.1

- 7.8 1,310.2 501.3 104.7 4.2 57.6 1,985.7 4,724.9

FY24

90.2 2,146.9 0.4 2,237.5

- - 7.8 58.4 1.4 152.8 220.3

3.4 7.2 921.2 502.5 69.0 1.5 76.0 1,580.5 4,038.3

FY23

90.2 2,141.8 0.4 2,232.4

- - - 1.7 2.7 143.4 147.9

3.0 0.0 1,377.6 431.4 78.1 61.4 19.1 1,970.6 4,350.8

FY22

90.2 1,822.2 0.3 1,912.8

- 2.4 3.5 1.6 2.3 128.9 138.6

38.0 5.1 1,177.6 324.8 55.4 4.2 86.7 1,691.8 3,743.1

Cr.

FY21

90.2 1,524.1 0.3 1,614.6

- 2.4 8.4 3.2 3.0 92.9 109.9

67.8 4.5 806.8 149.1 58.0 3.2 50.0 1,139.4 2,863.9

GROWING STRONGER, GOING FURTHER.

On Consolidated Basis

BALANCE SHEET – ASSETS

ASSETS Assets Non-Current Assets Property, Plant and Equipment Right to Use Assets Goodwill Other Intangible assets Intangible assets under development Deferred Tax Assets (net) Non-Current Tax Assets Other financial assets Other Non Current Assets Total Non-Current Assets

Current Assets Inventories Investments Trade Receivables Cash & Cash equivalents Other Bank balances Loans Other Financial Assets Other Current Assets Total Current Assets Total Assets

FY25

FY24

FY23

FY22

3.0 7.2 0.0 740.2 291.4 11.6 63.4 5.4 16.4 1,138.5

971.9 294.3 1,955.4 127.2 93.1 0.0 47.5 96.8 3,586.4 4,724.9

3.8 14.4 0.0 690.0 282.9 10.3 72.1 5.3 21.7 1,100.4

991.6 158.9 1,498.0 87.3 0.6 0.0 128.1 73.4 2,937.9 4,038.3

5.0 0.0 0.0 663.0 203.9 7.9 72.3 120.7 19.9 1,092.7

1,134.3 31.9 1,833.3 176.4 0.2 0.0 5.5 76.5 3,258.2 4,350.8

14.4 - 0.0 577.4 212.2 4.9 71.6 11.2 0.0 891.7

892.8 134.4 1,540.0 56.7 109.3 0.5 48.9 68.9 2,851.5 3,743.1

Cr.

FY21

20.9 - 0.4 523.1 131.0 6.0 73.6 9.4 0.0 764.5

525.5 83.0 1,162.6 85.6 175.0 - 28.1 39.6 2,099.3 2,863.9

GROWING STRONGER, GOING FURTHER.

On Consolidated Basis

CSR ACTIVITIES

CSR initiatives taken up by the Company are in the areas of Promoting Education, Healthcare, Eradicating Hunger, Empowerment of Women, Animal Welfare, Promotion of Sports and Rural Development Projects

Promoting Education

Animal Welfare

Medical Aid & Relief

GROWING STRONGER, GOING FURTHER.

THANK YOU

Company: Sharda Cropchem Limited

Investor Relation Advisors: Strategic Growth Advisors Pvt. Ltd.

CIN: L51909MH2004PLC145007

CIN: U74140MH2010PTC204285

Mr. Shailesh Mehendale – CFO cfo@shardaintl.com / finance@shardaintl.com Tel: +91 22 6678 2800

Mr. Deven Dhruva / Ms. Jinal Shah deven.dhruva@sgapl.net / jinal.shah@sgapl.net Tel: +91 98333 73300 / +91 97692 69759

← All Transcripts SHARDACROP Stock Page →

Sharda Cropchem Limited has informed the Exchange about Investor Presentation

Market Movers